TIM
GILD icon

Tevis Investment Management’s Gilead Sciences GILD Stock Holding History

Tevis Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,254
Closed -$77K – 120
2022
Q3 		$77K Buy
1,254
+191
+18% +$12K 0.07% 154
2022
Q2 		$63K Buy
1,063
+56
+6% +$3.47K 0.06% 166
2022
Q1 		$59K Buy
1,007
+432
+75% +$27.6K 0.05% 185
2021
Q4 		$42K Buy
+575
New +$39.6K 0.04% 222

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tevis Investment Management's GILD Position: Q4 2022 in Review

Tevis Investment Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 1,254 shares — an estimated $77K sold.

Tevis Investment Management first reported a position in GILD in Q4 2021 and held it in 4 quarters. The position peaked at $77K in Q3 2022. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Tevis Investment Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Tevis Investment Management sold 1,254 Gilead Sciences shares in Q4 2022, an estimated $77K.
  • Tevis Investment Management first reported a position in Gilead Sciences in Q4 2021 and held it in 4 quarters.
  • Tevis Investment Management's Gilead Sciences position peaked at $77K in Q3 2022.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Tevis Investment Management's 13F filing for Q4 2022, filed 31 Jan 2023.